Market Focus Target hospitals and health systems with Hemophilia Treatment Centers that manage 340B outpatient factor programs. Red Chip already works with 18 HTCs across 11 states and could leverage this network to expand into additional HTCs and related high-cost specialty meds programs.

Capabilities Highlight Position Red Chip’s expertise in billing and collections for high-cost prescription meds as a differentiator for clinics navigating complex reimbursement landscapes, especially those participating in limited-distribution drug programs and manufacturer partnerships.

Geographic Reach Capitalize on pharmacy licenses in all 50 states to support nationwide coverage for HTCs and associated outpatient factor programs, enabling scalable outsourcing of management services beyond current state presence.

Tech Enablement Leverage Red Chip’s tech stack to improve client workflows, data reporting, and compliance. Offer bundled digital solutions such as secure forms, CMS-ready integrations, and analytics dashboards for tracking 340B program performance and cash collection.

Growth Signals With a mid-market revenue range and a focused service offering, there is opportunity to upsell managed services, expand to additional HTCs, and pursue partnerships with manufacturers and distributors seeking market access for high-cost therapies in chronically ill populations.